Skip to main contentUnresolvablePlaintiff WinMixed ResultDefendant WinDefendant Win
Novo Nordisk A/s v. Caraco Pharmaceutical Laboratories, Ltd.
Federal CircuitMay 23, 2012No. 2010-1001
Mixed ResultNovo Nordisk A/S
Case Details
- Status
- Unpublished
- Procedural Posture
- Appeal from District Court decision; Federal Circuit affirmed in part and reversed in part
- Circuit
- Federal Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
Federal Circuit affirmed in part and reversed in part a patent dispute between Novo Nordisk and Caraco Pharmaceutical Laboratories regarding pharmaceutical patent validity and infringement issues.
Similar Rulings
Jean Adams v. Novo Nordisk A/S
9th CircuitMar 2022
Caraco Pharm.
U.S. Supreme CourtApr 2012
Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S
U.S. Supreme CourtNov 2011
Metabolite Laboratories, Inc. And Competitive Technologies, Inc. v. Laboratory Corporation of America Holdings (Doing Business as Labcorp)
Federal CircuitJun 2004
Laboratory Corp. of America Holdings v. Metabolite Laboratories, Inc.
U.S. Supreme CourtJun 2006
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. It is provided for informational and educational purposes only and does not constitute legal advice.